Trusted Resources: Education
Scientific literature and patient education texts
Nutritional Counseling Improves Quality Of Life and Preserves Body Weight in Systemic Immunoglobulin Light-Chain (AL) Amyloidosis
source: Nutrition
year: 2015
authors: Caccialanza R, Palladini G, Cereda E, Bonardi C, Milani P2, Cameletti B, Quarleri L, Cappello S, Foli A, Lavatelli F, Klersy C, Merlini G
summary/abstract:Objective:
Malnutrition is associated with mortality and impaired quality of life (QoL) in systemic immunoglobulin light-chain (AL) amyloidosis. The aim of this study was to determine whether nutritional counseling is beneficial to patients with AL.
Methods:
In this intervention study (ClinicalTrials.gov Identifier: NCT02055534), 144 treatment-naïve outpatients with AL were randomized to usual care (UC; n = 72) and nutritional counseling (NC; n = 72).
Results:
In the randomized population, although patients in the NC group maintained a stable body weight (weight loss [WL] = 0.6 kg; 95% confidence interval [CI], -1.0 to 2.1; P = 0.214), those in the UC group demonstrated a significant decrease (WL = 2.1 kg; 95% CI, 0.2-4.1; P = 0.003). However, the difference in weight between groups was not significant (mean WL difference = 1.6 kg; 95% CI, -0.7 to 3.9; P = 0.179). Patients in the NC group demonstrated more satisfactory energy intake (≥75% of estimated requirements, odds ratio, 2.18; 95% CI, 1.04-4.57; P = 0.048) and a significant increase in the mental component summary of QoL (Short form-36) at 12 mo (mean difference, 8.1; 95% CI, 2.3-13.9; P = 0.007), which was restored to a mean score of 53 (95% CI, 50-53), over the healthy population norms. NC was also associated with better survival (crude hazard ratio, 0.57; 95% CI, 0.35-0.94; P = 0.028).
Conclusions:
In outpatients with AL, NC was helpful in preserving body weight, effective in improving mental QoL, and associated with better survival.
organization: Fondazione IRCCS Policlinico San Matteo, ItalyDOI: 10.1016/j.nut.2015.04.011
read more
Related Content
-
Choosing Not to Continue Your Career After hATTR Amyloidosis DiagnosisDeciding to leave your job following you...
-
Exercises for Peripheral NeuropathyHere are exercises you can do to help ma...
-
FDA Approves Subcutaneous Daratumumab Plus VCd for Newly Diagnosed Light-Chain AmyloidosisThe FDA has approved daratumumab and h...
-
COVID-19 Screening ToolThe Coronavirus Self-Checker is an inter...
-
Novel Approaches for the Management of AL AmyloidosisPurpose of Review: Light-chain-associat...
-
How Can I Cope With Fatigue?Patients with AL amyloidosis may experie...
-
How Can I Cope With Diarrhoea?Patients should tell the medical staff a...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.